Entera Bio Ltd

ENTX65

Penny Stock

$1.59arrow_drop_down1.23%-$0.02

Penny Stock

ENTX65

$1.59

arrow_drop_down1.23%-$0.02

Penny Stock

Performance History

Key Stats
Open	$1.62
Prev. Close	$1.62
EPS	-0.26
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$58.56M
PE Ratio	-

	LOW	HIGH
Day Range	1.57	1.67
52 Week Range	0.52	3.35

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.26

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Entera Bio Ltd (ENTX)

Entera Bio Ltd (ENTX) is a biotechnology company that specializes in the development and commercialization of orally delivered biologics. The company is focused on improving the therapeutic potential of existing drugs by enhancing their oral absorption and delivery. ENTX leverages its proprietary technology platform, which utilizes the natural transport mechanisms of the body to enable the efficient absorption of large molecules in the gastrointestinal tract. This approach has the potential to revolutionize the delivery of biologic drugs, offering patients a more convenient and cost-effective treatment option.

ENTX's stock price history has shown significant volatility over the past few years. The stock reached its all-time high of $10.50 per share in September 2018 but has since experienced a decline. As of [date], the stock is trading at $4.75 per share. Despite the recent decline, ENTX has demonstrated resilience and continues to pursue its mission of advancing oral biologic drug delivery. The company has received positive news coverage and has been featured in several industry publications for its innovative approach to drug delivery.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Ms. Miranda J. Toledano M.B.A.
Headquarters: Jerusalem
Employees: 19
Exchange: NASDAQ

Keep an eye on Entera Bio Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Entera Bio Ltd's (ENTX) price per share?

The current price per share for Entera Bio Ltd (ENTX) is $1.59. The stock has seen a price change of -$0.02 recently, indicating a -1.23% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Entera Bio Ltd (ENTX)?

For Entera Bio Ltd (ENTX), the 52-week high is $3.35, which is 110.69% from the current price. The 52-week low is $0.52, the current price is 205.77% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Entera Bio Ltd (ENTX) a growth stock?

Entera Bio Ltd (ENTX) has shown an average price growth of -3.66% over the past three years. It has received a score of 70 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Entera Bio Ltd as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Entera Bio Ltd (ENTX) stock price performance year to date (YTD)?

As of the latest data, Entera Bio Ltd (ENTX) has a year-to-date price change of 142.79%. Over the past month, the stock has experienced a price change of -13.94%. Over the last three months, the change has been -7.02%. Over the past six months, the figure is -31.17%. Looking at a longer horizon, the five-year price change stands at -28.38%.

help

Is Entera Bio Ltd (ENTX) a profitable company?

Entera Bio Ltd (ENTX) has a net income of -$8.89M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -7.19K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.89M. Furthermore, the EBITDA is -$9.16M.

help

What is the market capitalization of Entera Bio Ltd (ENTX)?

Entera Bio Ltd (ENTX) has a market capitalization of $58.56M. The average daily trading volume is 1.62, indicating the stock's liquidity and investor engagement.